Hetero Drugs Valid
CEP Certificates (EDQM COS List)
Hetero Drugs Valid
CEP Database
Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.
- Total Records 136
- Latest End Date -
- Data Source EDQM
- Last Updated 2026-05-05
Company Overview
Social Profiles
Company Snapshot
Hetero Drugs Valid
7-2-A2, Hetero Corporate Industrial Estates, Sanath Nagar Hyderabad,Telangana
India
www.hetero.com/ contact@heterodrugs.com View on MapCEP Records Timeline (136 records)
Product
Proguanil hydrochloride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2011-182 - Rev 02
Substance No.
2002
Issue Date
2026-05-05
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2011-182 - Rev 02
Substance No.: 2002
Product
Indometacin
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2022-003 - Rev 01
Substance No.
92
Issue Date
2026-05-04
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-003 - Rev 01
Substance No.: 92
Product
Entecavir monohydrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2017-271 - Rev 06
Substance No.
2815
Issue Date
2026-04-30
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-271 - Rev 06
Substance No.: 2815
Product
Atovaquone, Form A, Process-II
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2025-001 - Rev 01
Substance No.
2192
Issue Date
2026-04-23
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2025-001 - Rev 01
Substance No.: 2192
Product
Tolterodine tartrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2020-032 - Rev 02
Substance No.
2781
Issue Date
2026-04-15
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2020-032 - Rev 02
Substance No.: 2781
Product
Nebivolol hydrochloride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2021-403 - Rev 02
Substance No.
2775
Issue Date
2026-04-10
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-403 - Rev 02
Substance No.: 2775
Product
Lansoprazole, LANCO Process
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2014-074 - Rev 02
Substance No.
2219
Issue Date
2026-03-23
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-074 - Rev 02
Substance No.: 2219
Product
Glimepiride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2007-156 - Rev 05
Substance No.
2223
Issue Date
2026-03-19
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2007-156 - Rev 05
Substance No.: 2223
Product
Esomeprazole magnesium dihydrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2014-333 - Rev 04
Substance No.
2787
Issue Date
2026-02-12
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-333 - Rev 04
Substance No.: 2787
Product
Topiramate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2020-130 - Rev 02
Substance No.
2616
Issue Date
2026-02-12
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2020-130 - Rev 02
Substance No.: 2616
Product
Lacosamide, Form-I
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2018-099 - Rev 04
Substance No.
2992
Issue Date
2026-02-10
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-099 - Rev 04
Substance No.: 2992
Product
Rivaroxaban
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2023-231 - Rev 02
Substance No.
2932
Issue Date
2026-02-04
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2023-231 - Rev 02
Substance No.: 2932
Product
Memantine hydrochloride, Form-I
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2025-110 - Rev 00
Substance No.
2773
Issue Date
2026-02-04
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2025-110 - Rev 00
Substance No.: 2773
Product
Amlodipine besilate, Process II
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2016-077 - Rev 02
Substance No.
1491
Issue Date
2026-02-03
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-077 - Rev 02
Substance No.: 1491
Product
Esomeprazole magnesium trihydrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2014-286 - Rev 02
Substance No.
2372
Issue Date
2025-12-10
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-286 - Rev 02
Substance No.: 2372
Product
Amlodipine besilate, Site-II
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2025-407 - Rev 00
Substance No.
1491
Issue Date
2025-12-04
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2025-407 - Rev 00
Substance No.: 1491
Product
Valaciclovir hydrochloride hydrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2018-102 - Rev 04
Substance No.
2751
Issue Date
2025-12-01
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-102 - Rev 04
Substance No.: 2751
Product
Valaciclovir hydrochloride hydrate, Site-II
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2024-054 - Rev 02
Substance No.
2751
Issue Date
2025-12-01
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-054 - Rev 02
Substance No.: 2751
Product
Allopurinol, Site-II
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2025-441 - Rev 00
Substance No.
576
Issue Date
2025-11-14
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2025-441 - Rev 00
Substance No.: 576
Product
Fosinopril sodium
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2013-018 - Rev 03
Substance No.
1751
Issue Date
2025-11-12
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2013-018 - Rev 03
Substance No.: 1751
Product
Lercanidipine hydrochloride, Hemihydrate, Amorphous form
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2024-593 - Rev 00
Substance No.
3052
Issue Date
2025-11-05
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-593 - Rev 00
Substance No.: 3052
Product
Mexiletine hydrochloride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2021-421 - Rev 01
Substance No.
1029
Issue Date
2025-09-15
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-421 - Rev 01
Substance No.: 1029
Product
Gabapentin
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2013-167 - Rev 04
Substance No.
2173
Issue Date
2025-09-04
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2013-167 - Rev 04
Substance No.: 2173
Product
Duloxetine hydrochloride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2012-305 - Rev 03
Substance No.
2594
Issue Date
2025-08-20
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-305 - Rev 03
Substance No.: 2594
Product
Citalopram hydrobromide, CTP Process
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2012-120 - Rev 05
Substance No.
2288
Issue Date
2025-08-01
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-120 - Rev 05
Substance No.: 2288
Product
Raltegravir potassium, Form III
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2023-193 - Rev 00
Substance No.
2887
Issue Date
2025-07-28
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2023-193 - Rev 00
Substance No.: 2887
Product
Levofloxacin hemihydrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2020-269 - Rev 02
Substance No.
2598
Issue Date
2025-07-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2020-269 - Rev 02
Substance No.: 2598
Product
Allopurinol
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2021-074 - Rev 03
Substance No.
576
Issue Date
2025-07-22
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-074 - Rev 03
Substance No.: 576
Product
Fenofibrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2012-290 - Rev 02
Substance No.
1322
Issue Date
2025-07-07
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-290 - Rev 02
Substance No.: 1322
Product
Rosuvastatin calcium
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2016-097 - Rev 02
Substance No.
2631
Issue Date
2025-07-03
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-097 - Rev 02
Substance No.: 2631
Product
Fexofenadine hydrochloride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2012-278 - Rev 04
Substance No.
2280
Issue Date
2025-06-13
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-278 - Rev 04
Substance No.: 2280
Product
Celecoxib
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2016-037 - Rev 02
Substance No.
2591
Issue Date
2025-06-13
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-037 - Rev 02
Substance No.: 2591
Product
Sertraline hydrochloride, Form-II, Process-II
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2014-195 - Rev 03
Substance No.
1705
Issue Date
2025-05-14
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-195 - Rev 03
Substance No.: 1705
Product
Omeprazole, Form-B
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2015-011 - Rev 03
Substance No.
942
Issue Date
2025-05-14
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2015-011 - Rev 03
Substance No.: 942
Product
Sertraline hydrochloride, Alternate process
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2012-218 - Rev 05
Substance No.
1705
Issue Date
2025-05-07
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-218 - Rev 05
Substance No.: 1705
Product
Pramipexole dihydrochloride monohydrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2010-328 - Rev 04
Substance No.
2416
Issue Date
2025-04-29
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2010-328 - Rev 04
Substance No.: 2416
Product
Perindopril tert-butylamine
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2010-118 - Rev 05
Substance No.
2019
Issue Date
2025-03-10
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2010-118 - Rev 05
Substance No.: 2019
Product
Aprepitant
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2017-196 - Rev 03
Substance No.
2757
Issue Date
2025-03-06
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-196 - Rev 03
Substance No.: 2757
Product
Moxifloxacin hydrochloride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2017-113 - Rev 02
Substance No.
2254
Issue Date
2025-03-06
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-113 - Rev 02
Substance No.: 2254
Product
Pregabalin, Process II
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2021-197 - Rev 03
Substance No.
2777
Issue Date
2025-03-05
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-197 - Rev 03
Substance No.: 2777
Product
Pantoprazole sodium sesquihydrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2008-289 - Rev 05
Substance No.
2296
Issue Date
2025-03-04
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2008-289 - Rev 05
Substance No.: 2296
Product
Valganciclovir hydrochloride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2022-398 - Rev 01
Substance No.
2930
Issue Date
2025-02-26
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-398 - Rev 01
Substance No.: 2930
Product
Citalopram hydrobromide
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2009-248 - Rev 05
Substance No.
2288
Issue Date
2025-02-17
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2009-248 - Rev 05
Substance No.: 2288
Product
Sildenafil citrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2013-002 - Rev 01
Substance No.
2270
Issue Date
2025-01-29
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2013-002 - Rev 01
Substance No.: 2270
Product
Montelukast sodium
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2012-318 - Rev 02
Substance No.
2583
Issue Date
2024-12-18
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-318 - Rev 02
Substance No.: 2583
Product
Ritonavir, Form-I
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2020-235 - Rev 01
Substance No.
2136
Issue Date
2024-12-13
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2020-235 - Rev 01
Substance No.: 2136
Product
Venlafaxine hydrochloride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2022-083 - Rev 01
Substance No.
2119
Issue Date
2024-12-10
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-083 - Rev 01
Substance No.: 2119
Product
Aciclovir
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2012-090 - Rev 03
Substance No.
968
Issue Date
2024-12-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-090 - Rev 03
Substance No.: 968
Product
Mirtazapine
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2023-188 - Rev 01
Substance No.
2338
Issue Date
2024-12-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2023-188 - Rev 01
Substance No.: 2338
Product
Omeprazole magnesium
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2021-021 - Rev 02
Substance No.
2374
Issue Date
2024-11-28
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-021 - Rev 02
Substance No.: 2374
Product
Omeprazole, Process II
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2016-245 - Rev 01
Substance No.
942
Issue Date
2024-11-26
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-245 - Rev 01
Substance No.: 942
Product
Famotidine
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2021-367 - Rev 01
Substance No.
1012
Issue Date
2024-10-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-367 - Rev 01
Substance No.: 1012
Product
Donepezil hydrochloride, Monohydrate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2022-301 - Rev 02
Substance No.
2582
Issue Date
2024-08-01
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-301 - Rev 02
Substance No.: 2582
Product
Isotretinoin
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2022-205 - Rev 01
Substance No.
1019
Issue Date
2024-07-31
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-205 - Rev 01
Substance No.: 1019
Product
Lisinopril dihydrate, Process II
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2016-197 - Rev 02
Substance No.
1120
Issue Date
2024-07-03
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-197 - Rev 02
Substance No.: 1120
Product
Lisinopril dihydrate, Process-III
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2022-434 - Rev 02
Substance No.
1120
Issue Date
2024-07-03
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-434 - Rev 02
Substance No.: 1120
Product
Valganciclovir hydrochloride, Site-II
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2024-111 - Rev 00
Substance No.
2930
Issue Date
2024-04-24
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-111 - Rev 00
Substance No.: 2930
Product
Dorzolamide hydrochloride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2017-050 - Rev 02
Substance No.
2359
Issue Date
2023-11-28
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-050 - Rev 02
Substance No.: 2359
Product
Pregabalin
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2016-296 - Rev 01
Substance No.
2777
Issue Date
2023-10-27
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-296 - Rev 01
Substance No.: 2777
Product
Carbidopa
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
CEP 2022-358 - Rev 00
Substance No.
755
Issue Date
2023-09-18
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-358 - Rev 00
Substance No.: 755
Product
Sertraline hydrochloride, Form-I
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2012-292 - Rev 02
Substance No.
1705
Issue Date
2023-08-25
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2012-292 - Rev 02
Substance No.: 1705
Product
Levodopa
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2022-320 - Rev 00
Substance No.
38
Issue Date
2023-03-14
End Date
-
Country
India
Identifiers
Certificate No.: R0-CEP 2022-320 - Rev 00
Substance No.: 38
Product
Solifenacin succinate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2016-293 - Rev 00
Substance No.
2779
Issue Date
2022-12-16
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2016-293 - Rev 00
Substance No.: 2779
Product
Lopinavir
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2020-396 - Rev 00
Substance No.
2615
Issue Date
2022-10-28
End Date
-
Country
India
Identifiers
Certificate No.: R0-CEP 2020-396 - Rev 00
Substance No.: 2615
Product
Olanzapine, Form-I, Process II
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2022-126 - Rev 00
Substance No.
2258
Issue Date
2022-06-22
End Date
-
Country
India
Identifiers
Certificate No.: R0-CEP 2022-126 - Rev 00
Substance No.: 2258
Product
Atovaquone, Form A
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2015-284 - Rev 00
Substance No.
2192
Issue Date
2022-04-11
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2015-284 - Rev 00
Substance No.: 2192
Product
Raloxifene hydrochloride
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2011-349 - Rev 00
Substance No.
2375
Issue Date
2020-11-30
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2011-349 - Rev 00
Substance No.: 2375
Product
Olanzapine, Form-I
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2012-215 - Rev 00
Substance No.
2258
Issue Date
2019-01-29
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2012-215 - Rev 00
Substance No.: 2258
Product
Amlodipine besilate
Substance
HETERO DRUGS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2006-003 - Rev 04
Substance No.
1491
Issue Date
2018-04-12
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2006-003 - Rev 04
Substance No.: 1491
Product
Paclitaxel, Produced by a semi-synthetic process
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2021-476 - Rev 01
Substance No.
1794
Issue Date
2026-05-05
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-476 - Rev 01
Substance No.: 1794
Product
Desloratadine
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2016-065 - Rev 02
Substance No.
2570
Issue Date
2026-04-30
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-065 - Rev 02
Substance No.: 2570
Product
Voriconazole, Form-I VZ Process
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2022-325 - Rev 02
Substance No.
2576
Issue Date
2026-04-17
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-325 - Rev 02
Substance No.: 2576
Product
Voriconazole, Form-I
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2018-184 - Rev 03
Substance No.
2576
Issue Date
2026-04-10
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-184 - Rev 03
Substance No.: 2576
Product
Finasteride
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2011-351 - Rev 04
Substance No.
1615
Issue Date
2026-04-01
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2011-351 - Rev 04
Substance No.: 1615
Product
Losartan potassium, Form I
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2009-247 - Rev 10
Substance No.
2232
Issue Date
2026-03-09
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2009-247 - Rev 10
Substance No.: 2232
Product
Gemcitabine hydrochloride, GA process
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2022-499 - Rev 01
Substance No.
2306
Issue Date
2026-02-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-499 - Rev 01
Substance No.: 2306
Product
Valsartan, VL Process Essentially Amorphous Form
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2021-152 - Rev 02
Substance No.
2423
Issue Date
2026-02-06
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-152 - Rev 02
Substance No.: 2423
Product
Capecitabine
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2014-355 - Rev 05
Substance No.
2762
Issue Date
2026-01-19
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-355 - Rev 05
Substance No.: 2762
Product
Trifluridine, Crystalline form
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2023-437 - Rev 00
Substance No.
2910
Issue Date
2026-01-06
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2023-437 - Rev 00
Substance No.: 2910
Product
Gemcitabine hydrochloride
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2009-208 - Rev 03
Substance No.
2306
Issue Date
2025-12-12
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2009-208 - Rev 03
Substance No.: 2306
Product
Eplerenone, Form-L Site-II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2025-487 - Rev 00
Substance No.
2765
Issue Date
2025-11-26
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2025-487 - Rev 00
Substance No.: 2765
Product
Rupatadine fumarate
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2024-294 - Rev 01
Substance No.
2888
Issue Date
2025-11-26
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-294 - Rev 01
Substance No.: 2888
Product
Erlotinib hydrochloride, Form-A
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2024-455 - Rev 00
Substance No.
3094
Issue Date
2025-11-24
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-455 - Rev 00
Substance No.: 3094
Product
Naproxen sodium
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2022-389 - Rev 01
Substance No.
1702
Issue Date
2025-11-19
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-389 - Rev 01
Substance No.: 1702
Product
Quetiapine Fumarate, Form-I
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2015-153 - Rev 04
Substance No.
2541
Issue Date
2025-11-17
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2015-153 - Rev 04
Substance No.: 2541
Product
Atorvastatin calcium, Form-I
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2018-049 - Rev 04
Substance No.
2191
Issue Date
2025-11-14
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-049 - Rev 04
Substance No.: 2191
Product
Docetaxel trihydrate
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2022-149 - Rev 02
Substance No.
2449
Issue Date
2025-10-27
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-149 - Rev 02
Substance No.: 2449
Product
Anastrozole, Form-II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2013-172 - Rev 02
Substance No.
2406
Issue Date
2025-10-17
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2013-172 - Rev 02
Substance No.: 2406
Product
Eplerenone, Form-L
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2019-263 - Rev 03
Substance No.
2765
Issue Date
2025-09-11
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2019-263 - Rev 03
Substance No.: 2765
Product
Naproxen
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2023-406 - Rev 00
Substance No.
731
Issue Date
2025-09-01
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2023-406 - Rev 00
Substance No.: 731
Product
Cyclophosphamide monohydrate
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2014-342 - Rev 02
Substance No.
711
Issue Date
2025-08-28
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-342 - Rev 02
Substance No.: 711
Product
Gefitinib
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2018-031 - Rev 02
Substance No.
2866
Issue Date
2025-08-22
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-031 - Rev 02
Substance No.: 2866
Product
Torasemide, Form-I
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2019-255 - Rev 02
Substance No.
2132
Issue Date
2025-07-29
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2019-255 - Rev 02
Substance No.: 2132
Product
Sorafenib tosilate, Form-III
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2021-324 - Rev 02
Substance No.
2931
Issue Date
2025-07-29
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-324 - Rev 02
Substance No.: 2931
Product
Hydralazine hydrochloride
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2018-287 - Rev 03
Substance No.
829
Issue Date
2025-07-22
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-287 - Rev 03
Substance No.: 829
Product
Letrozole, Form-III
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2012-145 - Rev 03
Substance No.
2334
Issue Date
2025-07-22
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-145 - Rev 03
Substance No.: 2334
Product
Imatinib mesilate, FORM-ALPHA (IF process)
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2024-574 - Rev 00
Substance No.
2736
Issue Date
2025-07-01
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-574 - Rev 00
Substance No.: 2736
Product
Irinotecan hydrochloride trihydrate, Form-B
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2019-021 - Rev 03
Substance No.
2675
Issue Date
2025-06-27
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2019-021 - Rev 03
Substance No.: 2675
Product
Abacavir sulfate, Form-II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2016-090 - Rev 01
Substance No.
2589
Issue Date
2025-06-12
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-090 - Rev 01
Substance No.: 2589
Product
Zidovudine
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2008-333 - Rev 07
Substance No.
1059
Issue Date
2025-05-23
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2008-333 - Rev 07
Substance No.: 1059
Product
Aripiprazole, Type-I
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2013-361 - Rev 02
Substance No.
2617
Issue Date
2025-05-16
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2013-361 - Rev 02
Substance No.: 2617
Product
Imatinib mesilate, FORM-β, ES Process
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2025-106 - Rev 00
Substance No.
2736
Issue Date
2025-05-14
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2025-106 - Rev 00
Substance No.: 2736
Product
Escitalopram oxalate, Process I
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2016-306 - Rev 01
Substance No.
2733
Issue Date
2025-05-13
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-306 - Rev 01
Substance No.: 2733
Product
Oseltamivir phosphate, Form-A
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2018-046 - Rev 02
Substance No.
2422
Issue Date
2025-05-09
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-046 - Rev 02
Substance No.: 2422
Product
Bicalutamide, Form-H1
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2012-254 - Rev 03
Substance No.
2196
Issue Date
2025-04-07
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-254 - Rev 03
Substance No.: 2196
Product
Atomoxetine hydrochloride, Form-A, Process II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2020-091 - Rev 02
Substance No.
2640
Issue Date
2025-03-28
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2020-091 - Rev 02
Substance No.: 2640
Product
Ramipril, Process-II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2021-281 - Rev 01
Substance No.
1368
Issue Date
2025-03-26
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-281 - Rev 01
Substance No.: 1368
Product
Entacapone, Form-A
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2012-314 - Rev 01
Substance No.
2574
Issue Date
2025-03-24
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-314 - Rev 01
Substance No.: 2574
Product
Olmesartan medoxomil, OQ process, crystalline form
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2024-040 - Rev 00
Substance No.
2600
Issue Date
2025-03-19
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-040 - Rev 00
Substance No.: 2600
Product
Temozolomide, Form-III
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2017-270 - Rev 02
Substance No.
2780
Issue Date
2025-02-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-270 - Rev 02
Substance No.: 2780
Product
Aripiprazole, Process-II, Type-I
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2017-254 - Rev 03
Substance No.
2617
Issue Date
2024-12-11
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-254 - Rev 03
Substance No.: 2617
Product
Ramipril
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2006-147 - Rev 06
Substance No.
1368
Issue Date
2024-12-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2006-147 - Rev 06
Substance No.: 1368
Product
Levetiracetam, Form-I Process-II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2014-113 - Rev 02
Substance No.
2535
Issue Date
2024-11-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-113 - Rev 02
Substance No.: 2535
Product
Carboplatin
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2015-121 - Rev 02
Substance No.
1081
Issue Date
2024-11-15
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2015-121 - Rev 02
Substance No.: 1081
Product
Oxaliplatin
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2015-112 - Rev 01
Substance No.
2017
Issue Date
2024-10-14
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2015-112 - Rev 01
Substance No.: 2017
Product
Olmesartan medoxomil, Crystalline
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2017-305 - Rev 03
Substance No.
2600
Issue Date
2024-09-27
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-305 - Rev 03
Substance No.: 2600
Product
Atazanavir sulfate
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2019-217 - Rev 01
Substance No.
2898
Issue Date
2024-09-11
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2019-217 - Rev 01
Substance No.: 2898
Product
Terbinafine hydrochloride, Process II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2012-310 - Rev 03
Substance No.
1734
Issue Date
2024-09-11
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-310 - Rev 03
Substance No.: 1734
Product
Pemetrexed disodium 2.5-hydrate
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2022-497 - Rev 00
Substance No.
3046
Issue Date
2024-09-03
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-497 - Rev 00
Substance No.: 3046
Product
Pioglitazone hydrochloride, PI-process
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2023-004 - Rev 00
Substance No.
2601
Issue Date
2024-08-30
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2023-004 - Rev 00
Substance No.: 2601
Product
Nevirapine, Additional site
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2016-076 - Rev 01
Substance No.
2255
Issue Date
2024-07-18
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-076 - Rev 01
Substance No.: 2255
Product
Lamivudine, LAN process, Form II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2013-168 - Rev 01
Substance No.
2217
Issue Date
2024-05-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2013-168 - Rev 01
Substance No.: 2217
Product
Cisplatin
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2014-273 - Rev 01
Substance No.
599
Issue Date
2024-04-12
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-273 - Rev 01
Substance No.: 599
Product
Imatinib mesilate, Form-β
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2018-289 - Rev 02
Substance No.
2736
Issue Date
2024-03-28
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-289 - Rev 02
Substance No.: 2736
Product
Irbesartan
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2017-104 - Rev 04
Substance No.
2465
Issue Date
2024-03-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-104 - Rev 04
Substance No.: 2465
Product
Imatinib mesilate, Form α, Process II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2018-222 - Rev 04
Substance No.
2736
Issue Date
2024-02-20
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-222 - Rev 04
Substance No.: 2736
Product
Zoledronic acid monohydrate
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2021-181 - Rev 00
Substance No.
2743
Issue Date
2023-10-27
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-181 - Rev 00
Substance No.: 2743
Product
Escitalopram oxalate, Process II
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
CEP 2017-080 - Rev 06
Substance No.
2733
Issue Date
2023-10-27
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-080 - Rev 06
Substance No.: 2733
Product
Telmisartan
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2022-041 - Rev 00
Substance No.
2154
Issue Date
2023-08-08
End Date
-
Country
India
Identifiers
Certificate No.: R0-CEP 2022-041 - Rev 00
Substance No.: 2154
Product
Imatinib mesilate, Form-α
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2016-275 - Rev 00
Substance No.
2736
Issue Date
2023-06-09
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2016-275 - Rev 00
Substance No.: 2736
Product
Lamivudine, LML Process
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R0-CEP 2019-082 - Rev 01
Substance No.
2217
Issue Date
2023-03-20
End Date
-
Country
India
Identifiers
Certificate No.: R0-CEP 2019-082 - Rev 01
Substance No.: 2217
Product
Atomoxetine hydrochloride
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2015-128 - Rev 01
Substance No.
2640
Issue Date
2022-08-29
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2015-128 - Rev 01
Substance No.: 2640
Product
Dutasteride
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2016-126 - Rev 00
Substance No.
2641
Issue Date
2022-07-26
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2016-126 - Rev 00
Substance No.: 2641
Product
Simvastatin
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2014-058 - Rev 00
Substance No.
1563
Issue Date
2021-08-09
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2014-058 - Rev 00
Substance No.: 1563
Product
Cilazapril
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2006-146 - Rev 02
Substance No.
1499
Issue Date
2021-03-02
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2006-146 - Rev 02
Substance No.: 1499
Product
Lamivudine
Substance
HETERO LABS LIMITED Hyderabad IN
Certificate No.
R1-CEP 2008-160 - Rev 02
Substance No.
2217
Issue Date
2017-08-10
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2008-160 - Rev 02
Substance No.: 2217
Status Breakdown
136 total- Valid
Official Source
All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).
Visit EDQMRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Country
India
Identifiers
Certificate No.: CEP 2011-182 - Rev 02
Substance No.: 2002
100% Official Data
Directly from the EDQM CEP database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.